Citadel Advisors’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$295K Buy
+3,000
New +$282K ﹤0.01% 11159
2024
Q4
Sell
-200
Closed -$19.6K 14942
2024
Q3
$19.6K Buy
200
+100
+100% +$9.7K ﹤0.01% 12789
2024
Q2
$9.28K Hold
100
﹤0.01% 13145
2024
Q1
$9.31K Sell
100
-400
-80% -$36.2K ﹤0.01% 13510
2023
Q4
$43.4K Buy
+500
New +$41.4K ﹤0.01% 11933
2023
Q3
Sell
-1,200
Closed -$102K 14696
2023
Q2
$102K Sell
1,200
-1,200
-50% -$102K ﹤0.01% 10905
2023
Q1
$200K Sell
2,400
-3,100
-56% -$257K ﹤0.01% 10188
2022
Q4
$467K Buy
5,500
+2,000
+57% +$165K ﹤0.01% 8383
2022
Q3
$264K Buy
+3,500
New +$283K ﹤0.01% 9847

Other funds holding IXJ

Citadel Advisors's IXJ Position: Q2 2026 in Review

Citadel Advisors sold out of iShares Global Healthcare ETF (IXJ) in Q2 2026, closing a stake of 56,307 shares — an estimated $5.3M sold.

Citadel Advisors first reported a position in IXJ in Q1 2014 and held it in 33 quarters. The position peaked at $15.5M in Q3 2015. 302 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Citadel Advisors reported no remaining iShares Global Healthcare ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 56,307 iShares Global Healthcare ETF shares in Q2 2026, an estimated $5.3M.
  • Citadel Advisors first reported a position in iShares Global Healthcare ETF in Q1 2014 and held it in 33 quarters.
  • Citadel Advisors's iShares Global Healthcare ETF position peaked at $15.5M in Q3 2015.
  • 302 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.